All posts tagged ross camidge

  • Camidge.Slider.940x530

    University of Colorado’s Online Screening for Rare Lung Cancer Subtypes Opens Door to New Kind of Clinical Trial

    CU Cancer Center clinical trial tests the drug ponatinib against lung cancer with mutation in the gene FGFR1. Online questionnaire and free lung cancer tissue testing at CU determines eligibility.

Ross Camidge, MD, chief of the Lung Cancer program at
the University of Colorado Cancer Center, helped to enroll Rabinowitz
in the phase 1 trial of a new ALK inhibitor.
Camidge
Ross Camidge, MD, PhD
Ross Camidge, teaching
Dandelion
2327090343_cfd56b7636_b
Camidge
Pills
camidge-basket_award